US FDA Getting More Money Up Front Under Cures Bill Revisions

 
• By Derrick Gingery

Additional funding would arrive beginning in FY 2017 as House pushes bill to Senate.

FDA entrance sign 2016

More from US FDA

More from Agency Leadership